Regulation of epithelial-mesenchymal transformation (EMT) is of central importance both in normal development and in disease. During heart development, cells of the superficial epicardial mesothelium undergo EMT to give rise to precursor cells of the coronary vasculature and cardiac fibroblasts. Here we report that the α 4 β 1 integrin ligand, VCAM-1, inhibits EMT of chick epicardial mesothelial cells stimulated by TGFβ isoforms. We further investigated the molecular basis of this inhibition using cultured chick embryonic and rat adult epicardial mesothelial cells. We observed that VCAM-1 increased cortical actin filaments at intercellular junctions and reduced stress fibers across epicardial cells. VCAM-1 inhibited stress fiber formation by TGFβ1, TGFβ2, TGFβ3 and lysophosphatidic acid and altered Rho activity stimulated by TGFβ3. This was accompanied by an increase in tyrosine phosphorylation of p190RhoGAP. All three TGFβ isoforms weakened intercellular adhesion, reduced membrane localization of β-catenin and E-cadherin and stimulated epicardial EMT in chick hearts. Each of these effects was restricted by simultaneous VCAM-1 treatment. Our data support the hypothesis that VCAM-1 can alter epicardial EMT at two key points: it limits Rhodependent events such as stress fiber formation and it maintains the association of β-catenin and E-cadherin with the adherens junction.
Introduction
The establishment and maintenance of cell-cell adhesion is a critical feature of epithelia. The regulated loss of cell-cell adhesion is an equally important process in which cells can undergo epithelial-mesenchymal transformation (EMT) (Thiery, 2002 (Thiery, , 2003b . EMT occurs in many situations during normal development and also in pathologic conditions such as the progression of malignant epithelial tumors. Molecular regulation of establishment and maintenance of cell-cell adhesion or EMT involves signaling pathways that affect the specialized adhesive structures in desmosomes, adherens junctions and tight junctions as well as their association with intermediate filaments and microfilaments (Braga, 2002) .
EMT is an essential process during the development of the normal heart. EMT of endocardial cells underlying the atrioventricular canal and outflow tract establishes the endocardial cushions which will participate in the development of the valves and septa of the heart (Eisenberg and Markwald, 1995) . A distinct population of cells that undergo EMT during heart development is derived from the superficial epicardium (Markwald et al., 1996) . The epicardium is a mesothelium superficial to the myocardium, which with the parietal pericardium defines the pericardial cavity that surrounds the heart. Consistent with its anatomic definition as a mesothelium, epicardial cells express both cytokeratins and vimentin, fulfilling a molecular profile for mesothelia (Moll et al., 1982; Munoz-Chapuli et al., 2001) . EMT of epicardial mesothelial cells (EMCs) overlying the AV sulcus and ventricles is an essential process that populates the subepicardial space with mesenchymal cells. These cells form the coronary arteries and cardiac fibroblasts that invade the myocardium (Dettman et al., 1998; Gittenberger-de Groot et al., 1998; Perez-Pomares et al., 1997) . Molecules that regulate epicardial EMT have not been specifically defined but are thought to include members of the FGF and TGFβ families (Merki et al., 2005; Morabito et al., 2001) . These molecules are predicted to be myocardially derived since a null mutation in Friend of GATA-2 (FOG-2), a GATA family cofactor exclusively expressed in the myocardium, fully inhibits epicardial EMT (Tevosian et al., 2000) . Thus, inductive signals that stimulate epicardial EMT are produced in the myocardium and are regulated by GATA transcription factors.
EMCs that populate the surface of the heart are derived from the proepicardium, an outgrowth of the septum transversum (Viragh and Challice, 1981; Viragh et al., 1993) . Cells from the proepicardium attach and migrate over the myocardium until the entire surface of the atria, ventricles and proximal outflow tract are covered by the epicardial mesothelium. Proepicardial cells utilize a number of cell surface integrins to mediate adhesion and motility. Mice deficient for α 4 -integrin (α 4 ) have demonstrated that the α 4 β 1 integrin receptor is absolutely required for proepicardial attachment, migration and long-term adhesion of the epicardium to the myocardium (Sengbusch et al., 2002; Yang et al., 1995) . To circumvent the requirement for α 4 in the transition of the proepicardium to the epicardium, we used antisense in the fully developed chick epicardium to knock down α 4 in vivo. In this study, we observed that EMCs that expressed antisense α 4 became highly invasive and invaded the myocardium at rates 4-5 times that of normal EMCs (Dettman et al., 2003) . Since loss of α 4 β 1 from epicardial cells resulted in increased invasiveness, we postulated that one possible function of α 4 was to inhibit EMT in the presence of factors or signals that stimulated EMT. While α 4 is known to be required for motility in some cell-types Han et al., 2003; Kil et al., 1998) , it also functions to inhibit invasion in other contexts. High expression of α 4 suppresses metastasis formation of LB lymphoma cells in secondary lymphoid organs (Gosslar et al., 1996) . Inhibition of metastasis requires the C-terminus of α 4 implicating a signaling mechanism. In lung fibroblasts, binding of α 4 β 1 to fibronectin inhibits basement membrane invasion. This was shown to involve a signaling pathway that activates the tumor suppressor PTEN, a phosphatase that inhibits signaling through PKB/Akt pathway (White et al., 2003) . In transformed human mammary epithelial cells, expression of α 4 on the cell surface is lost in combination with the acquisition of an invasive phenotype (Woods Ignatoski et al., 2003) . Downregulation of α 4 was shown to result from signaling from the erbB-2 receptor through Rac 1 and p38MAPK. Therefore, since in some cases loss of α 4 is linked with increased cell invasion and α 4 signaling is implicated in the maintenance of intercellular adhesion, we reasoned that α4β1 signaling could regulate the adhesive state of epicardium in the developing heart. An emerging paradigm for α 4 signaling involves its ability to regionally modulate Rho-GTPase activity within cells. In Jurkat T-cells or CHO cells that express α 4 , adhesion-dependent inhibition of lamellipodia formation is accompanied by binding of the ADP-ribosylation factor GTPase-activating protein (ArfGAP) to the α 4 -paxillin complex. This decreases Arf activity and results in decreased Rac activity on the lateral sides of migrating cells (Nishiya et al., 2005) . When the α 4 -paxillin complex is regionalized within the cell, Rac activity becomes polarized. Another example of an α 4 mediated signal that alters Rho GTPase activity is in cultured melanoma cells where the formation of stress fibers is inhibited upon binding to the α 4 β 1 ligand H2 found in the FNIII4-5 repeats of fibronectin (Moyano et al., 2003a,b) . This was accompanied by the production of cellular protrusions. Adhesion to H2 activated p190RhoGAP within protrusions and reduced Rho activity in melanoma cells, suggesting that α 4 antagonizes stress fiber formation by decreasing Rho activity (Moyano et al., 2003b) .
The α 4 β 1 integrin receptor binds two primary ligands: vascular cell adhesion molecule (VCAM-1) and fibronectin. In the developing mouse heart, VCAM-1 is expressed in cells of the precardiac mesoderm, in compact myocardium prior to proepicardial attachment and in myocardium during later heart development (Baldwin et al., 1991; Kwee et al., 1995) . Disruption of the gene encoding VCAM-1 in mice resulted in aberrant epicardial formation similar to that derived from the α 4 integrin knockout demonstrating the essential role of VCAM-1 in proepicardial attachment, migration and adhesion (Kwee et al., 1995) . Fibronectin isoforms are expressed by the myocardium and epicardium during the time when epicardial formation and EMT occur in the chick (Bouchey et al., 1996) . Thus, as proepicardial cells attach and migrate on the heart and as epicardial cells undergo EMT, the α 4 β 1 integrin ligands VCAM-1 and fibronectin are present in the heart.
Here we report that the soluble form of the α 4 β 1 integrin ligand VCAM-1 (sVCAM-1) stimulates changes to epicardial cells that restrict EMT. In collagen gel assays and chick embryonic hearts, TGFβ3 increased epicardial invasion and this was significantly reduced by co-stimulation with sVCAM-1. We utilized a rat epicardial mesothelial cell line to study the molecular basis of the effects of sVCAM-1 on epicardial cells. In rat EMCs, sVCAM-1 promoted the formation of apical cortical actin filaments and decreased basal stress fibers. TGFβ3 stimulated the formation of stress fibers and this was accompanied with increased Rho activity. Co-stimulation with sVCAM-1 inhibited stress fibers and reduced maximal activation of Rho. Rat EMCs treated with TGFβ3 did not undergo EMT but had weakened intercellular adhesion and reduced localization of β-catenin and E-cadherin within cell junctions, consistent with cellular changes associated with EMT. sVCAM-1 strengthened adhesion and increased association of β-catenin and E-cadherin with intercellular junctions. TGFβ1 and TGFβ2 increased EMT in chick epicardial cells as well as increased stress fibers and weakened intercellular adhesion in rat EMCs and all of these effects were antagonized by sVCAM-1. Thus, our observations suggest that sVCAM-1 alters pathways within epicardial mesothelial cells that restrict EMT stimulated by TGFβ. These pathways modulate Rho activity and promote stable adherens junctions in EMCs.
Materials and methods

Chicken eggs
Fertile White Leghorn chicken (Gallus gallus) eggs were obtained from Phil's Fresh Eggs (Forreston, IL) and were incubated in a humidified bird hatching incubator at 37°C. Embryos were staged according to the method of Hamburger and Hamilton (1951) .
Antibodies and probes
Polyclonal antibodies used in this study were: H-276 to the N-terminus and C-19 to the C-terminus of human VCAM-1 (Santa Cruz), and anti-RhoGAP (Cell Signaling Technology). Mouse monoclonal antibodies were: anti-Rho (Cytoskeleton), anti-β-catenin (Clone 14, BD Transduction Labs), anti-vimentin Clone 40E-C (Developmental Systems Hybridoma Bank), anti-E-cadherin Clone 36 (BD Transduction Labs), anti-RhoGAP (clone D2D6, Upstate), antiphospho tyrosine (P-Tyr-100, Cell Signaling Technology). Secondary antibodies used in this study were: goat anti-rabbit and goat anti-mouse Alexa 488, goat anti-rabbit and goat anti-mouse Alexa 568 (Invitrogen, Molecular Probes). Texas Red-X phalloidin, propidium iodide and 4′,6 diamidino-2-phenylindole and dihydrochloride (DAPI) were from Invitrogen, Molecular Probes.
Cells and reagents
Rat EMCs were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with glucose (4.5% w/v), fetal bovine serum (10% v/v) and penicillin/streptomycin (10 μg/ml). Chick EMCs were cultured in M199 medium containing antibiotics as was described in Dettman et al. (1998) . All cells were cultured in a 5% CO 2 tissue culture incubator at 37°C. Human recombinant sVCAM-1 was obtained from R&D systems. This is a 97 kDa fragment of VCAM-1 that contains seven extracellular Ig domains, including two α4β1 binding sites, but lacks the transmembrane and cytoplasmic domains. Human recombinant TGFβ1 and TGFβ2 were obtained from Prepro Tech and TGFβ3 was obtained from R&D Systems. Y26732 (Calbiochem) was used at a final concentration of 10 μM. Lysophosphatidic acid (Sigma) was resuspended in PBS with 0.1% (w/v) bovine serum albumin and used at a final concentration of 15 μM.
Viruses
Replication defective adenoviruses were amplified from single plaques and tested for purity by PCR of viral particles using gene specific primers. AdnlacZ was reported previously (Dettman et al., 1998) . Adenoviruses were amplified in human embryonic kidney 293 cells and cesium purified according to the method for the AdEasy system (He et al., 1998) .
Collagen gel assay
Collagen gels made from rat-tail collagen 1 (BD Biosciences) were neutralized with NaOH and diluted to a final concentration of 2 mg/ml in sterile PBS. Neutralized collagen was placed in 24 well plate (700 μl per well) and allowed to gel at 37°C for 60 min. Gels were washed several times in serum free M199 medium. Chick HH24 hearts were dissected in sterile PBS and placed onto the surface of drained collagen gels. Epicardial monolayers were allowed to grow on the collagen surface in serum free M199 medium for 2 days in a 5% CO 2 tissue culture incubator at 37°C. Medium was then replaced with serum free M199 containing TGFβ1 (1 ng/ml), TGFβ2 (1 ng/ml), TGFβ3 (1 ng/ml), VCAM-1 (100 ng/ml) or in combination. Collagen gels were then incubated for 2 days in a 5% CO 2 tissue culture incubator at 37°C. Gels were fixed in 4% formaldehyde (v/v) made from fresh paraformaldehyde in PBS for 1 h, and then washed in PBS. Fixed gels were embedded in 1.5% agarose and equilibrated in 30% sucrose (w/v) overnight at 4°C. Embedded gels were sectioned on a Leica CM1850 cryostat and sections were stained with DAPI (300 nM) and propidium iodide (5 μM) and imaged on a Zeiss LSM510 confocal microscope.
Organ culture EMT Assay
EMT in cultured hearts was done essentially as in Dettman et al., 2003 . Chick HH27 hearts were dissected in sterile PBS and placed into serum free M199 medium containing antibiotics and fungizone in non-adherent 24 well dishes. AdnlacZ (2 × 10 7 viral particles/ml, final concentration) was added to the medium and incubated with hearts for 48 h either with or without the addition of factors. Hearts were washed in PBS and fixed in formaldehyde (4% v/v) and incubated in lacZ staining buffer for 1-2 h at 37°C: BluoGal (1 mg/ml, Invitrogen), K-ferrocyanide (0.2 M), K-ferricyanide (0.2 M), MgCl 2 (1 mM). Hearts were then embedded in paraffin (Fisher) and sectioned coronally (10 μm). Cells were scored as follows. The criterion for scoring a cell was that it contained a clearly stained nucleus. Cells were scored in every third section to avoid counting the same cell more than once. In coronal sections where cells were scored, all cells were scored, both in the atria and ventricles. Random fields were not chosen within each section. Cells were scored based on their position: either superficially in the epicardium or deep in the subepicardium or myocardium. At least 500 cells were counted for each heart analyzed. Superficial cells were defined as non-invasive and deep cells were defined as invasive. The percentage of invasive cells was calculated as the number of invasive cells divided by the total number of cells scored for each heart. The mean percentage of invasive cells was calculated by determining the average of a minimum of three hearts studied for each condition. Data are presented in bar graphs with error bars equal to the standard deviation. Statistical significance was determined using a paired t-test.
Immunocytochemistry and actin staining
Sterile glass coverslips were coated with rat-tail collagen 1 (10 μg/ml, BD Biosciences) in individual 35 mm culture plates and allowed to dry. For chick embryonic epicardial cells, HH24 hearts were dissected in sterile PBS, transferred onto the surface of coated coverslips and covered with 500-600 μl of M199 medium supplemented with fetal bovine serum (10% v/v) and penicillin/streptomycin (10 μg/ml). Epicardial monolayers were allowed to form around hearts on the surface of coverslips for 48 h. Hearts were then removed, cells were washed with PBS twice and medium was replaced with serum free M199 medium with penicillin/streptomycin (10 μg/ml). For rat EMCs, cells were washed in PBS and then treated with trypsin-EDTA (0.05% w/v) for 2 min. Once detached, DMEM containing 10% (v/v) serum and antibiotics was added and cells were counted using a hemacytometer. Rat EMCs were diluted to 5 × 10 4 cells/ml with culture medium and 2 ml of medium plus cells was added to each dish containing a coverslip. Cells were then placed in a 5% CO 2 tissue culture incubator at 37°C for 1-2 days until they reached confluency on the surface of the coverslip. Cells were washed with PBS twice and then placed in serum free DMEM overnight. For either chick or rat epicardial monolayers, factors were then added directly to the medium covering the cells at the final concentrations and for the times specifically described below. After treatment, cells were washed in PBS and fixed in 4% formaldehyde (v/v) made from fresh paraformaldehyde in PBS for 10 min. Coverslips were then washed in PBS and then in PBS supplemented with bovine serum albumin (0.1% w/v) and triton X-100 (0.1% v/v) (PBT) to permeabilize membranes. All antibodies or stains were diluted in PBT prior to incubation with coverslips. For actin staining, coverslips were incubated with Texas Red-X phalloidin (5 U/ml) for 30 min at 37°C and then washed in PBS. After staining, coverslips were mounted onto glass microscope slides (Fisher) using aqua polymount (Fisher) and were imaged on a Zeiss LSM510 confocal microscope.
Rho activation assays
Activated Rho was detected using detection assays from Cytoskeleton. Rat EMCs were grown to confluency in DMEM containing 10% (v/v) serum and antibiotics on 10 cm tissue culture dishes. Cells were serum-starved overnight in serum free DMEM and factors were added to the dishes for the times indicated without replacing the medium. Cells were washed in PBS and lysis buffer was added to the dishes. 2 mg of total protein from cleared lysates was added to rhotekin-RBD beads and mixed for 60 min at 4°C. Beads were washed according to the method of the assay at 4°C and boiled in Laemlli sample buffer for 5 min. Sample buffer including beads were loaded on a 15% PAGE gel and proteins resolved on a BioRad Mini Protean II system. Proteins were transferred to Hybond nitrocellulose and blots were blocked in Tris saline buffer containing tween (0.1% v/v) and powdered milk (5% w/v). Primary antibodies were incubated overnight and secondary antibodies for 2 h in blocking buffer. Bands were visualized using West Dura (Pierce) on X-ray film.
Dispase assay
Confluent rats EMCs were cultured on 60 mm dishes in DMEM containing 10% (v/v) serum and antibiotics. This medium contains 200 mM calcium. Cells were treated with VCAM-1 (100 ng/ml), TGFβ3 (1 ng/ml) or a combination of the two in serum free DMEM for 24 h. Cells were washed in PBS and incubated with dispase-2 (Roche Diagnostics) for 30 min or until monolayers lifted from the surface of the dish. Monolayers were washed and then mechanically agitated on an orbital shaker for 15 min. Monolayer fragments were counted as in Lorch et al. (2004) . The mean percentage of monolayer fragments was calculated by determining the average number of fragments from a minimum of four monolayers studied for each condition. Data are presented in bar graphs with error bars equal to the standard deviation. Statistical significance was determined using a paired t-test.
Cell fractionation and immunoblotting
Confluent rat EMCs were cultured on 10 cm dishes in DMEM containing 10% (v/v) serum and antibiotics and then serum-starved overnight. Cells were treated with TGFβ3 (1 ng/ml), VCAM-1 (100 ng/ml) or a combination of the two as above for 30 min or 2 h. Cells were then rinsed in PBS and removed from plates by scraping in lysis buffer: Tris, pH 7.5 (20 mM), EDTA (0.5 mM), EGTA (0.5 mM), 2-mercaptoethanol (10 mM), aprotinin (25 mg/ml) and leupeptin (25 mg/ml). Cells were disrupted in a Dounce homogenizer using 15 strokes and then left on ice for 20 min. Low speed centrifugation (5000×g) was performed to remove nuclei. The nuclear pellet was dissolved in Triton solubilization buffer: Tris, pH 7.5 (20 mM), Triton X-100 (0.25% v/v) EDTA (0.5 mM), EGTA (0.5 mM), 2-mercaptoethanol (10 mM), aprotinin (25 mg/ml) and leupeptin (25 mg/ml). The cell supernatant, containing both membrane and cytosolic fractions, was centrifuged at 100,000×g for 45 min at 4°C. Supernatant was removed as the cytosolic fraction. The pellet was dissolved in Triton solubilization buffer and then centrifuged at 16,000×g in a microcentrifuge at 4°C. The supernatant was removed as the Triton soluble membrane fraction. Proteins were quantified using a Bradford assay (Pierce) and equal amounts were loaded onto 4-20% SDS PAGE gels (BioRad). Proteins were transferred to nitrocellulose and probed as above.
Immunoprecipitation
Confluent rat EMCs were cultured on 10 cm dishes in DMEM containing 10% (v/v) serum and antibiotics, serum-starved overnight, treated as above and washed with PBS twice. Cells were solubilized in RIPA buffer for 5 min, scraped and spun at 4°C at 10,000 rpm for 10 min. Protein in cleared supernatants was quantified using the Bradford method and 4 μg of antiRhoGAP or anti-β-catenin was added to 300-900 μg of total cellular protein.
Tubes were rocked overnight at 4°C. 20 μl of Protein A/G PLUS agarose (Santa Cruz Biotechnology) was then added to each sample and tubes were rocked at 4°C for 1 h. Agarose beads were washed, boiled in sample buffer and proteins loaded onto 7.5% SDS PAGE gels (BioRad). Proteins were transferred to nitrocellulose and probed as above.
Results
VCAM-1 reduces epicardial EMT in hearts
We previously tested the function of α 4 in epicardium by infecting cells at the heart surface with an adenovirus that expressed an antisense sequence to α 4 . We observed that cells infected at the epicardial surface with this virus were much more likely to undergo EMT and invade the myocardium (Dettman et al., 2003) . This observation led us to the hypothesis that α 4 played a role in regulating EMT at the heart surface. We postulated that the presence of α 4 actively stabilizes the epithelial phenotype of these cells. Without this influence, epicardial cells are subjected only to inductive pathways that stimulate EMT. Based on our results, we predicted that when α 4 β 1 is engaged by ligand at the epicardial surface EMT is restricted. We tested this by explanting HH24 chick hearts to the surface of drained collagen gels and allowing epicardial monolayers to grow over the surface. Monolayers were treated with the EMT stimulatory molecule TGFβ3 (Azhar et al., 2003; Boyer et al., 1999; Kaartinen et al., 2002; Nawshad and Hay, 2003) to enhance EMT or were treated simultaneously with TGFβ3 and sVCAM-1. We observed that TGFβ3 (1 ng/ml) increased the number of invasive mesenchymal cells within the collagen as compared with untreated cultures (Figs. 1A, B) . Treatment with sVCAM-1 (100 ng/ml) did not stimulate invasion into the collagen gel (Fig.  1C) . In cultures treated simultaneously with TGFβ3 and sVCAM-1, the number of invasive mesenchymal cells was reduced as compared to cultured treated with TGFβ3 (Figs. 1B,  D) . These results were consistent with our hypothesis that α 4 β 1 ligands can restrict epicardial EMT.
To further test the ability of VCAM-1 to alter epicardial EMT, we utilized a quantitative assay for epicardial EMT in cultured chicken Hamburger and Hamilton (HH) stage 27 hearts. Our method is depicted in Fig. 1E . In this experiment, hearts are dissected from HH27 embryos and placed in serum free medium in non-adhesive culture plates. Hearts are incubated with a replication incompetent adenovirus that expresses nuclear localized β-galactosidase (AdnlacZ) and cultured for an additional 48-h period in serum free medium. Using this technique, we previously showed that AdnlacZ infects EMCs only at the epicardial surface of the heart with approximately 90% of infected cells remaining in the epicardium in the absence of an additional positive signal. Moreover, these culture conditions did not result in gross morphological alterations to the hearts (Dettman et al., 2003) . After culturing, hearts are fixed, stained for β-galactosidase expression and embedded in paraffin. Each heart is sectioned and individual sections are inspected for lacZ+ nuclei. Cells are scored for their position in the atria or ventricles as epicardial, subepicardial or myocardial (Figs. 1F-I ). Cells scored in the subepicardium or myocardium are defined as cells that have undergone EMT. Similar to our earlier experiments, we observed that when hearts were not stimulated, invasion occurred at a rate of approximately 12% (Fig. 1J) . The observation of a low basal rate of invasion is presumably due to already stimulated EMT pathways in the heart at the time of culture. When hearts were treated with TGFβ3, we observed that infected EMCs were more invasive than in unstimulated controls (Figs. 1F, H ). TGFβ3 at 10 ng/ml and 1 ng/ml increased EMT from 12% (basal level) to 43% and 29%, respectively. This indicated that epicardial cell invasion of hearts was increased in a dose-dependent manner by TGFβ3. counted that were in subepicardium or myocardium. *P < 0.0001 for TGFβ3 (10 ng/ml) compared with untreated. **P < 0.02 for TGFβ3 (10 ng/ml) + sVCAM-1 (100 ng/ml) compared with TGFβ3 (10 ng/ml).
# P < 0.003 for TGFβ3 (1 ng/ml) compared with untreated.
## P < 0.006 for TGFβ3 (1 ng/ml) + sVCAM-1 (100 ng/ml) compared with TGFβ3 (1 ng/ml). Error bars are standard deviations. P values were determined by paired t-test.
We used sVCAM-1 (100 ng/ml) to test if α 4 β 1 ligands alter TGFβ3 stimulated EMT. Treatment of hearts with sVCAM-1 alone did not significantly stimulate or reduce EMT (Figs. 1G,  J) . However, sVCAM-1 reduced epicardial cell invasion to 29% in combination with 10 ng/ml TGFβ3 and to 17% in combination with 1 ng/ml TGFβ3. Both observations of reduced epicardial invasion by sVCAM-1 were statistically significant suggesting that VCAM-1 interferes with EMT stimulation. Together, collagen gel assays and heart culture assays were consistent with roles for TGFβ3 in stimulating EMT and our hypothesis that α 4 β 1 ligands restrict epicardial EMT in hearts.
VCAM-1 alters the actin cytoskeleton of chick EMCs
To determine the cellular mechanism through which VCAM-1 inhibits epicardial EMT we cultured chick epicardial monolayers from HH24 hearts, serum-starved them and treated them with varying concentrations of sVCAM-1 for various times. Monolayers were examined for any phenotypic changes consistent with EMT. sVCAM-1 did not stimulate morphologic changes to the phenotype of chick EMCs in any of these experiments. We treated chick monolayers with sVCAM-1 and next stained chick epicardial monolayers with phalloidin to visualize filamentous actin and with an antibody to β-catenin to visualize cell-cell junctions (Fig. 2) . Cells from untreated monolayers had actin filaments both across cells (stress fibers) and in association with cell junctions (cortical actin filaments) ( Fig. 2A) . β-catenin was localized in cell junctions (adherens junctions) (Fig. 2E) . We tested if actin filaments were altered in the presence of TGFβ3. Serum-starved chick epicardial monolayers treated with TGFβ3 (1 ng/ml) for 30 min dramatically changed from the characteristic cuboidal, mesothelial shape to an elongated shape (Fig. 2J) . These cells had stress fibers and β-catenin was localized in small streaks instead of in cell junctions (Figs. 2B, F) . These changes were consistent with cellular events of EMT: reorganization of actin into stress fibers to generate actin-myosin based contraction and the dissolution of organized cell junctions. In cells treated with sVCAM-1 (100 ng/ml) for 30 min, we observed increased cortical actin filaments and decreased stress fibers (Fig. 2C) . Junctional localization of β-catenin persisted in sVCAM-1 treated cells (Fig. 2G) . Increased association of cortical actin filaments with cadherins is associated with formation, stabilization and strengthening of adherens junctions (Braga et al., 1997; Jou and Nelson, 1998; Kuroda et al., 1997; Takaishi et al., 1997) . Since we had observed that sVCAM-1 had increased cortical actin filaments of cultured chick EMCs and it had reduced invasion of chick epicardial cells in collagen gels and in cultured hearts, we postulated that sVCAM-1 might be stimulating the preservation of intercellular adhesion. To test this, we simultaneously treated serum-starved chick epicardial monolayers with TGFβ3 (1 ng/ Fig. 2 . sVCAM-1 inhibits cell shape changes in chick EMCs treated with TGFβ3. Confocal imaging of chick EMCs grown from explanted HH24 chick hearts on collagen-coated coverslips. Hearts were removed and remaining EMC layers were serum-starved for 12 h prior to treatment. Untreated monolayers are shown in panels A, E and I. Chick EMCs were treated for 30 min with (B, F, J) TGFβ3 (1 ng/ml), (C, G, K) sVCAM-1 (100 ng/ml) and (D, H, L) TGFβ3 (1 ng/ml) and sVCAM-1 (100 ng/ml). Coverslips were stained with Texas Red-X phalloidin to visualize f-actin (red, top row) and anti-β-catenin (green, middle row). Phase contrast images are shown in the bottom row. Scale bars are 20 μm. ml) and sVCAM-1 (100 ng/ml). Remarkably, the presence of sVCAM-1 not only prevented the morphologic changes to the cells (Fig. 2L) but it prevented the reorganization of actin into stress fibers and the alteration of β-catenin in cell junctions (Figs. 2D, H) . Moreover, sVCAM-1 appeared to increase cortical actin as compared with untreated monolayers even in the presence of TGFβ3 (Fig. 2D) . Thus, these observations were consistent with a new hypothesis that sVCAM-1 stimulates changes in chick epicardial cells to increase cortical actin in association with junctional complexes to increase the strength of intercellular adhesion. This effect predominates over the EMTstimulatory effects of TGFβ3 and provides an explanation for reduced epicardial invasion in the presence of sVCAM-1 (Fig. 1) and increased invasion when EMCs express an antisense mRNA to chick α 4 integrin (Dettman et al., 2003) .
VCAM-1 alters TGFβ3 stimulated stress fiber formation and Rho activation
Molecules that stimulate EMT, such as TGFβ, activate Rho to increase stress fibers in epithelial cells (Bhowmick et al., 2001b ). Rho signaling is important for epicardial EMT, which was inhibited in vivo by the Rho Kinase inhibitor Y26732 (Lu et al., 2001) . Therefore, we postulated that epicardial invasion stimulated by TGFβ3 in hearts involves activation of Rho and the ability of sVCAM-1 to inhibit stress fibers and diminish invasion was, in part, to produce signals that alter Rho activation. To test this we utilized an adult rat EMC cell line that maintains the epithelial phenotype of embryonic EMCs (Eid et al., 1992 (Eid et al., , 1994 Wada et al., 2003) and can be grown to sufficient numbers to perform biochemical assays for Rho activation. We observed that cells remained epithelial at either low or high passage density, f-actin was organized in stress fibers and cortical arrays and β-catenin was localized to the cell periphery in adherens junctions (Figs. 3A-C) . Similar to chick embryonic EMCs, sVCAM-1 (100 ng/ml) treated rat EMCs had fewer basal stress fibers, increased cortical actin fibers and junctional β-catenin localization (Figs. 3D-F) . We tested if TGFβ3 could cause morphologic changes in rat EMCs consistent with EMT. We found that these cells did not change their shape either with a 1 ng/ml or a 10 ng/ml treatment of TGFβ3. Treatment with either dose of TGFβ3 for Fig. 3 . Alteration of the actin cytoskeleton and adherens junctions by TGFβ3 and sVCAM-1 in rat EMCs. Confocal imaging of serum-starved rat EMC monolayers untreated (A-C) or treated for 30 min with (D-F) sVCAM-1 (100 ng/ml), (G-I) TGFβ3 (1 ng/ml) and (J-L) GRGDNP (0.6 μg/ml). Fixed monolayers were examined for localization of f-actin and β-catenin as indicated above. Panels are optical sections through the apical portion of the monolayer. Treatments are indicated on the right. Scale bars represent 20 μm.
up to 5 days also had no effect. Treatment of serum-starved rat EMCs however, caused changes to actin and β-catenin. TGFβ3 (1 ng/ml) increased stress fibers and altered β-catenin localization in cell junctions (Figs. 3G-I ). While accumulation of stress fibers was similar to what we observed in chick embryonic EMCs, TGFβ3 did not alter β-catenin to the high degree that we observed in these cells. To rule out that increased cortical actin is stimulated by other integrin receptor ligands, we stimulated rat EMCs with the peptide GRGDNP. This peptide binds at high affinity to activated integrins other than α 4 β 1 (Ruoslahti, 1996) . GRGDNP (0.6 μg/ml) modestly increased stress fibers and stress fiber thickness (Figs. 3J, L) . Increased stress fibers stimulated by GRGDNP were not accompanied by any changes to junctional β-catenin (Fig.  3K ). This suggests that binding of the core residues RGD produces actin reorganization in a manner similar to TGFβ3 treatment (and not sVCAM-1), but that this does not appear to alter the adherens junction.
We tested if sVCAM-1 could inhibit stress fiber formation in serum-starved rat EMCs stimulated by either TGFβ3 (1 ng/ml) or the Rho stimulatory molecule lysophosphaditic acid (15 μM) (Ridley and Hall, 1994) . Rat EMCs treated with either TGFβ3 (Figs. 3G, I ) or lysophosphaditic acid (Figs. 4C, H) primarily formed stress fibers. When treated simultaneously with sVCAM-1 (100 ng/ml), rat EMCs mainly formed cortical actin (Figs. 4D,  E, I, J) . These results were consistent with our observations in chick embryonic EMCs (Figs. 2D, H) and our hypothesis that VCAM-1 inhibits stress fibers stimulated via Rho activation. Lysophosphaditic acid stimulated epicardial invasion in cultured hearts to approximately the same degree as TGFβ3 and sVCAM-1 inhibited this (Supplementary Fig. 1 ). This indicated that Rho activation by LPA is sufficient to increase epicardial invasion and supported our hypothesis that sVCAM-1 antagonizes Rho activation. To determine if TGFβ3 activated Rho, we stimulated serum-starved rat EMCs with TGFβ3 (1 ng/ml) for different times and assayed for Rho activation using rhotekin-RBD beads Fig. 4 . Modulation of stress fibers, Rho activity and p190RhoGAP activity in rat EMCs by VCAM-1. Confocal imaging of serum-starved rat EMCs treated for 30 min with the following: (A, F) Untreated, (B, G) sVCAM-1 (100 ng/ml), (C, H) lysophosphatidic acid (15 μM), (D, I) lysophosphatidic acid (15 μM) plus sVCAM-1 (100 ng/ml) and (E, J) TGFβ3 (1 ng/ml) plus sVCAM-1 (100 ng/ml). Fixed monolayers were stained with Texas Red-X phalloidin to visualize f-actin. Scale bars are 20 μm in panels A-E and 5 μm in panels F-J. (K) Western blot demonstrating Rho activity in rat EMCs treated with TGFβ3 (1 ng/ml) for the indicated times and assayed by rhotekin-GBD pull down. (L) Western blot demonstrating Rho activity assayed by rhotekin-GBD pull down in rat EMCs pre-treated with sVCAM-1 (100 ng/ml) for 20 min and then TGFβ3 (1 ng/ml) was added for the indicated times. (M) Immunoprecipitation of p190RhoGAP from rat EMCs treated with sVCAM-1 (100 ng/ml) for the indicated times. Top blot is probed with anti-phospho tyrosine, bottom is the stripped blot probed with anti-p190RhoGAP. (Fig. 4K) . We observed that Rho activity increased after 10 min of TGFβ3 treatment and that this increase was sustained through 60 min. This increase in activity was consistent with the timing of actin cytoskeletal changes in both lysophosphaditic acid and TGFβ3 treated rat EMCs. To determine if VCAM-1 could alter TGFβ3 stimulated Rho activation, we pre-treated cells with sVCAM-1 (100 ng/ml) for 20 min and then treated with TGFβ3 for various times (Fig. 4L) . In this experiment, we observed maximal Rho-GTP activity after 20 min of TGFβ3 stimulation, which diminished to levels equivalent or lower than the untreated sample by 60 min. Peak Rho activity at 20 min in cells treated with both sVCAM-1 and TGFβ3 was about a factor of two lower than the level of Rho in cells treated with TGFβ3 alone in the same experiment (data not shown). Thus in rat EMCs, sVCAM-1 altered the dynamics of TGFβ3 stimulated Rho activity consistent with its ability to inhibit actin stress fibers.
Sustained activation of p190RhoGAP was demonstrated to be a downstream target of α 4 β 1 signaling in human melanoma cells and could explain the differential Rho activity we observed in rat EMCs (Moyano et al., 2003b) . To test if p190RhoGAP is activated as a result of VCAM-1 treatment, we treated serumstarved rat EMCs with sVCAM-1 (100 ng/ml) for various times and assayed p190RhoGAP for tyrosine phosphorylation (Fig.  4M) . We observed that within 5 min of sVCAM-1 treatment, p190RhoGAP was significantly activated and this increase was sustained through 30 min. Thus, activation of p190RhoGAP as a result of stimulation by sVCAM-1 is consistent with our observations of stress fiber inhibition and altered Rho activation by TGFβ3 in the presence of sVCAM-1.
VCAM-1 antagonizes TGFβ3 stimulated weakening of intercellular junctions
Our experiments in both chick embryonic and rat EMCs indicated that VCAM-1 promotes polymerization of apical cortical actin fibers, which is consistent with strengthening of intercellular adhesion. To further investigate this finding, we utilized an in vitro method to measure the strength of intercellular contacts of rat EMCs Hudson et al., 2004; Lorch et al., 2004) . In this assay, cells were grown until they formed confluent monolayers. Monolayers were then treated for 24 h with TGFβ3 (1 ng/ml or 10 ng/ml), sVCAM-1 (100 ng/ml) or a combination of TGFβ3 and sVCAM-1. None of these treatments induced morphologic EMT (Figs. 5A-D) . Fig. 5 . Strength of intercellular adhesion in rat EMCs treated with TGFβ3 and VCAM-1. Phase contrast images of cultured rat EMC monolayers that were (A) untreated, (B) treated with sVCAM-1 (100 ng/ml), (C) treated with TGFβ3 (10 ng/ml) and (D) treated with TGFβ3 (10 ng/ml) plus sVCAM-1 (100 ng/ml) for 24 h prior to treatment with dispase-2. Scale bars are 100 μm. (E) Photographs of rat EMC monolayers lifted by dispase-2. Four experiments are shown for the following conditions as listed on the right: VCAM-1 (100 ng/ml), TGFβ3 (1 ng/ml), TGFβ3 (1 ng/ml) and sVCAM-1 (100 ng/ml). (F) Quantification of dispase assay in which monolayers were treated with TGFβ3 and sVCAM-1. *P < 0.0002 for TGFβ3 (10 ng/ml) compared with untreated.
# P < 0.0002 for TGFβ3 (10 ng/ml) plus sVCAM-1 (100 ng/ml) compared with TGFβ3 10 ng/ml. **P < 0.007 for TGFβ3 (1 ng/ml) compared with untreated.
## P < 0.006 for TGFβ3 (1 ng/ml) plus sVCAM-1 (100 ng/ml) compared with TGFβ3 1 ng/ml. Error bars are standard deviations. P values were determined by paired t-test.
Monolayers were lifted from plates using dispase-2, a protease that cleaves ECM proteins but preserves intercellular adhesions. We assessed the strength of intercellular adhesion by counting the number of fragments derived from monolayers after mechanical disruption (Figs. 5E, F) . We observed that in untreated monolayers of EMCs fragmenting was rare but that monolayers treated with TGFβ3 became highly fragmented (Figs. 5E, F) . This was consistent with a role for TGFβ3 in weakening intercellular adhesion of EMCs. Similar to untreated monolayers, EMCs treated with sVCAM-1 were almost entirely unfragmented after mechanical disruption (Figs. 5E, F) and sVCAM-1 treatment appeared to inhibit the limited fragmentation observed in untreated monolayers; however, this was not statistically significant (Fig. 5F ). sVCAM-1 significantly reduced fragmentation caused by TGFβ3 (Figs. 5E, F) . Therefore, through this analysis we conclude that while morphologic EMT does not occur, intercellular adhesion in rat EMCs is weakened after TGFβ3 treatment. Stimulation by sVCAM-1 maintains strength of cell-cell adhesion even in the presence of TGFβ3.
VCAM-1 maintains junctional localization of β-catenin and E-cadherin in rat EMCs
Specialized protein complexes organized within apical cell junctions mediate intercellular adhesion in epithelia. These include adherens junctions, tight junctions and desmosomes. Adherens junctions hold cells together by establishing Ecadherin-dependent cell-cell adhesion. E-cadherin based intercellular adhesion in part requires the association of the cytoplasmic tail of cadherin with β-catenin. Loss of association of E-cadherin with β-catenin is a regulated process that reduces the association of actin filaments with the adherens junction. This in turn weakens the entire intercellular junction (reviewed in Lilien and Balsamo, 2005) . Once released from E-cadherin, β-catenin can move to the cytoplasm where, ultimately it can be stabilized and translocate to the nucleus where with the TCF/ Lef1 co-factor, it can regulate gene transcription. Our hypothesis is that VCAM maintains or strengthens cell-cell adhesion so we tested this by determining the localization of the junctional proteins β-catenin and E-cadherin after exposure to TGFβ3 and sVCAM-1. We had observed that a 30-min Fig. 6 . Localization and cell fractionation of adherens junction proteins in rat EMCs treated with TGFβ3 and sVCAM-1. Confocal imaging of serum-starved rat EMC monolayers untreated (A, D) or treated with TGFβ3 (1 ng/ml) for 30 min (B, E) or co-treatment with TGFβ3 (1 ng/ml) and sVCAM-1 (100 ng/ml) for 30 min (C, F). Monolayers were analyzed for β-catenin or E-cadherin localization as indicated at the right. Scale bars are 20 μm. (G) Western analysis of β-catenin from rat EMCs treated with TGFβ3 (1 ng/ml), sVCAM-1 (100 ng/ml) or the combination for either 30 or 120 min as indicated above the line. Total cellular protein was fractionated into membrane, cytosolic and nuclear fractions as indicated on the right. Antibodies used in the immunoblot (IB) are indicated on the left. treatment with TGFβ3 (1 ng/ml) altered β-catenin junctional localization in serum-starved chick (Fig. 2F) and rat (Figs. 3H,  6B ) EMCs. TGFβ3 (1 ng/ml) also decreased E-cadherin localization at cell borders within the same time (Fig. 6E) . These observations were consistent with TGFβ3 mediating signals that alter the interaction between E-cadherin and β-catenin in EMCs. We tested if VCAM-1 could restore localization of these proteins to the adherens junction. We treated serum-starved rat EMCs with TGFβ3 (1 ng/ml) or TGFβ3 (1 ng/ml) plus sVCAM-1 (100 ng/ml) for 30 min, and fixed and stained cells for β-catenin and E-cadherin. In cells treated with TGFβ3, both β-catenin and E-cadherin localization in cellular junctions was disrupted (Figs. 6B, E) . However, in cells treated with both TGFβ3 and sVCAM-1, we observed that both β-catenin (Fig. 6C ) and E-cadherin (Fig. 6F) were intensely localized in the adherens junction. Thus, VCAM-1 Fig. 7 . VCAM-1 inhibits actin stress fibers, loss of junctional proteins and weakening of intercellular adhesion by TGFβ1 and TGFβ2. Confocal imaging of serumstarved rat EMC monolayers untreated (A, F, K) or treated for 30 min with TGFβ1 (1 ng/ml, B, G, L), co-treatment with TGFβ1 (1 ng/ml) and sVCAM-1 (100 ng/ml, C, H, M), TGFβ2 (1 ng/ml, D, I, N), co-treatment with TGFβ2 (1 ng/ml) and sVCAM-1 (100 ng/ml, E, J, O). Monolayers were analyzed for f-actin (top row) β-catenin (middle row) or E-cadherin (bottom row) localization as indicated at the right. Scale bar is 5 μm for all panels. (P) Quantification of dispase assay in which monolayers were treated with TGFβ1 (1 ng/ml), co-treated with TGFβ1 (1 ng/ml) and sVCAM-1 (100 ng/ml), TGFβ2 (1 ng/ml), co-treated with TGFβ2 (1 ng/ml) and sVCAM-1 (100 ng/ml) for 30 min and sVCAM-1 at 100 ng/ml. *P < 0.001 for TGFβ1 (1 ng/ml) compared with untreated.
# P < 0.01 for TGFβ1 plus sVCAM-1 compared with TGFβ1. **P < 0.01 for TGFβ2 (1 ng/ml) compared with untreated. ## P < 0.02 for TGFβ2 plus sVCAM-1 compared with TGFβ2. Error bars are standard deviations. P values were determined by paired t-test. promotes pathways that restore or maintain β-catenin and Ecadherin in the adherens junction as part of its role in maintaining intercellular contacts.
If TGFβ3 treatment stimulates loss of association of β-catenin from E-cadherin, then β-catenin would be lost from the membrane. We tested this possibility by analyzing membrane, cytosolic and nuclear fractions for β-catenin (Fig. 6G) . Rat EMCs treated with TGFβ3 (1 ng/ml) had diminished β-catenin in the membrane and cytosolic fractions after 2 h of treatment and a modest increase of β-catenin in the nuclear fraction (Fig.  6G) . This indicated that TGFβ3 stimulates relocalization of β-catenin from the membrane to the cytoplasm and nucleus. sVCAM-1 (100 ng/ml) treatment maintained or increased β-catenin in the membrane fraction and antagonized the loss of β-catenin from the membrane by TGFβ3 (Fig. 6G ). These observations indicate that VCAM-1 stabilizes β-catenin at the membrane and provides an explanation for the ability of VCAM-1 to maintain strong intercellular adhesion in the presence of TGFβ3 (Fig. 5) .
VCAM-1 alters EMT stimulated by TGFβ1 and TGFβ2
Thus far our experiments supported a role for stimulation of EMT by TGFβ3 and inhibition by VCAM-1. However, the specific factor (or factors) that stimulates epicardial EMT in vivo has not been defined. We therefore tested if other TGFβ isoforms could stimulate epicardial EMT as well as changes to the actin cytoskeleton and intercellular adhesion in EMCs and whether VCAM-1 could restrict this. In rat EMCs we observed that TGFβ1 and TGFβ2 (1 ng/ml) increased stress fibers and altered β-catenin and E-cadherin localization at intercellular junctions in serum-starved rat EMCs after 30 min, similar to Bars indicate percent of total cells counted that were in subepicardium or myocardium. *P < 0.01 for TGFβ1 (1 ng/ml) compared with untreated.
# P < 0.02 for TGFβ1 (1 ng/ml) plus VCAM-1 (100 ng/ml) compared with TGFβ1 (1 ng/ml). *P < 0.01 for TGFβ2 (1 ng/ml) compared with untreated.
## P < 0.002 for TGFβ2 (1 ng/ml) plus VCAM-1 (100 ng/ml) compared with TGFβ2 (1 ng/ml). Error bars are standard deviations. P values were determined by paired t-test.
what we observed after TGFβ3 treatment (Figs. 7A-O) . Simultaneous sVCAM-1 treatment inhibited stress fibers and promoted cortical actin polymerization. This was also what we observed in chick embryonic EMCs (Supplementary Fig. 2 ). Both TGFβ1 and TGFβ2 weakened intercellular adhesion as measured by the dispase-2 assay and sVCAM-1 inhibited this (Fig. 7P) . Finally, TGFβ1 and TGFβ2 stimulated epicardial cell invasion in collagen gels (Figs. 8B, C) and cultured hearts (Fig.  8G ) and sVCAM-1 reduced this (Figs. 8E, F) . Interestingly, TGFβ1 appeared to stimulate invasion of collagen most robustly (Fig. 8B) and was more sensitive to inhibition by sVCAM-1, where it was reduced to less than 10% in chick hearts (Fig. 8G) . At 1 ng/ml, each TGFβ isoform stimulated epicardial invasion to more than 30%, with TGFβ2 having the strongest effect. These observations indicate that the ability of VCAM-1 to alter TGFβ stimulated EMT is not restricted to one isoform and suggest that all three isoforms alter common intracellular signaling pathways sensitive to inhibitory signals generated by VCAM-1.
Discussion
Until now it has not been clear why integrin α 4 expression persists in the epicardium after proepicardial cell migration. Expression of α 4 in epicardium after its formation was thought to fulfill an adhesive role to the myocardium, which expresses the VCAM-1 ligand. Here we provide evidence suggestive of a new role for α 4 signaling in regulating Rho activity and the intercellular junction in epithelia. EMT in the epicardium is a process that simultaneously yields invasive cells and maintains the mesothelium. Therefore, it is likely that both invasiveness and epithelial maintenance are carefully regulated. Persistent expression of α 4 in the epicardium and the ability of VCAM-1 to restrict EMT as demonstrated by our experiments suggest that α 4 expression and signaling are important for regulating epicardium maintenance throughout heart development. This hypothesis also predicts that loss of α 4 from epicardium would lead to an increased propensity of EMCs to invade the heart as stimulated by secondary pathways that normally promote invasiveness. This was precisely what we observed in vivo when α 4 was targeted using an antisense strategy (Dettman et al., 2003) .
VCAM-1 antagonizes TGFβ stimulated EMT in epicardial cells
TGFβs are important stimulatory molecules in EMT. They are involved in many types of EMT including development, metastasis and fibrosis (Thiery, 2002 (Thiery, , 2003a ). Their precise role in stimulating EMT has only recently been clarified. Multiple pathways are likely to be influenced by TGFβ signaling during EMT including the wnt/β-catenin pathway, the phosphatidylinositol-3 kinase, PKB/Akt pathway, the Rho pathway and the Smad pathway (Zavadil and Bottinger, 2005) . Activation of the phosphatidylinositol-3 kinase, PKB/Akt pathway is known to antagonize glycogen synthase kinase activity, which otherwise destabilizes cytoplasmic β-catenin and Snail, both putative regulators of EMT (Bachelder et al., 2005; Zhou et al., 2004) . In mouse palate development, TGFβ3 activates transcription of the β-catenin binding protein Lef-1 via the Smad pathway and a dominant negative mutant of Lef-1 blocks TGFβ3 stimulated palatal EMT (Nawshad and Hay, 2003) . However, Lef-1 overexpression was not sufficient to overcome the inhibition of palatal EMT by anti-TGFβ3 suggesting that a TGFβ-dependent, non-Smad pathway is required for EMT. This additional role could be in activating Rho signaling since activation of Rho and Rho kinase is essential for palate fusion and midline EMT (Kaartinen et al., 1995 (Kaartinen et al., , 2002 , epicardial EMT and smooth muscle differentiation (Lu et al., 2001 ) and mouse mammary epithelial cell EMT (Bhowmick et al., 2001a) . However, while TGFβ stimulated EMT can be blocked by inhibiting Rho signaling, it could not be induced by constitutive activation of Rho (Bhowmick et al., 2001a,b) . This may happen because other pathways that are normally influenced by TGFβ are not affected by constitutively active Rho. Thus, it seems that in order for TGFβ to induce EMT, multiple intracellular pathways must be activated in concert and that inhibition of isolated pathways (e.g. Smad, LEF-1 or Rho) is sufficient to block EMT.
Regulation of EMT could be achieved by antagonizing TGFβ via any of the pathways that it activates. In situations where epithelial maintenance is essential, such as in the epicardium, this could explain how some cells undergo EMT and others do not. Another example is in the kidney where Smad activation by TGFβ is antagonized by BMP7 (Zeisberg et al., 2003) . BMP7 is highly expressed in the kidney and can inhibit EMT of renal tubular epithelial cells. In mesangial cells, BMP7 inhibits nuclear accumulation of Smad3 and activates Smad5 and the inhibitory Smad6. Therefore, BMP7 represents a signal that can hold the Smad3-dependent pathway in check. Our results suggest, however, a VCAM-1-dependent antagonism of TGFβ-dependent Rho activation and β-catenin localization in adherens junctions. First, similar to what Moyano et al. (2003b) observed in melanoma cells with the α 4 ligand H2, we observed that sVCAM-1 activates p190Rho-GAP in rat EMCs and this alters Rho activation by TGFβ3 (Fig.  4) . Given that inhibition of Rho (Bhowmick et al., 2001a) and Rho kinase (Kaartinen et al., 2002 ) is sufficient to block TGFβ induced EMT, the observed modulation of Rho by sVCAM-1 should be sufficient to reduce EMT, and this is what we observed in chick hearts (Figs. 1 and 8 and Supplementary Fig.  1 ). Second, VCAM-1 treatment inhibited TGFβ3-dependent loss of β-catenin and E-cadherin from the intercellular junction (Fig. 6) . Loss of association of β-catenin and E-cadherin from the adherens junction itself should play a significant role in EMT by disrupting cell-cell adhesion and pathways that limit this could reduce EMT. Our observations also raise the possibility that β-catenin could play an additional role in epicardial EMT, after it becomes cytoplasmic. This idea is supported by the observation that Wnt9b is expressed in the developing mouse heart indicating that a Wnt signal is temporally and spatially present when epicardial EMT occurs (Merki et al., 2005) . By limiting the ability of β-catenin to be released from the adherens junction, VCAM-1 could not only maintain intercellular adhesion but also limit the ability of β-catenin to signal in the nucleus. The functional significance of a Wnt signal through β-catenin during epicardial EMT remains a topic of study.
sVCAM-1 treatment of epicardial cells leads to strengthened intercellular adhesion
Our observations suggest that sVCAM-1 treatment of rat EMCs leads to events that increase cortical actin association with the adherens junction and stabilize adherens junction components at the membrane. Both events are consistent with strengthening of intercellular adhesion. How could this occur? Increased association of actin filaments with adherens junctions is known to increase the strength of intercellular adhesion (Braga et al., 1997; Jou and Nelson, 1998; Kuroda et al., 1997; Takaishi et al., 1997) . However, regulation of cortical actin assembly at the adherens junction is not well defined. This process requires α-catenin and actin polymerization by an α-catenin/formin-1 complex that preferentially produces unbranched actin filaments (Kobielak et al., 2004) . Since formin-1 binds to α-catenin, it is localized to the adherens junction. α 4 β 1 ligands such as VCAM-1 could stimulate pathways that promote the association of formin-1 with α-catenin and the adherens junction, promoting the polymerization of unbranched actin filaments at the intercellular junction.
The E-cadherin/β-catenin complex is stabilized or destabilized by phosphorylation events (Lilien and Balsamo, 2005) . Serine phosphorylation of E-cadherin at residues 684, 686 and 692 stabilizes its binding to β-catenin (Lickert et al., 2000; Stappert and Kemler, 1994) . Binding of β-catenin at these residues also masks a PEST degradation-targeting domain effectively decreasing the rate of turnover of E-cadherin. Tyrosine phosphorylation of β-catenin at residues 142, 489 and 654 regulates loss of association between β-catenin and Ecadherin or α-catenin. For example, phosphorylation at Tyr-654 by EGFR or Src kinase disrupts the E-cadherin binding site for β-catenin (Roura et al., 1999) . Phosphorylation of β-catenin at Tyr-142 by Fyn, Fer or cMet kinases disrupts α-catenin binding to β-catenin and results in loss of cadherin binding, intercellular adhesion and transport of β-catenin to the cytoplasm (Piedra et al., 2003; Roura et al., 1999) . Phosphorylation of Tyr-489 by Abl also results in the loss of association of β-catenin from Ecadherin (Rhee et al., 2002) . α 4 β 1 ligands such as VCAM-1 could alter pathways that influence the serine phosphorylation of E-cadherin or tyrosine phosphorylation of β-catenin to maintain the association of E-cadherin and α-catenin with β-catenin. This could potentially also maintain the association of formin-1 with the adherens junction to increase the polymerization of unbranched actin filaments as we have observed.
Still another possibility is that Rho activation may alter the adherens junction. Rho was shown to bind to the catenin, Ecadherin complex in Drosophila embryos indicating that Rho is recruited directly to the adherens junction (Magie et al., 2002) . The role of active Rho in establishing or maintaining the adherens junction is less clear. Downstream effectors of Rho such as PRK2 kinase, and the diaphanous formin mDia1, promote intercellular adhesion suggesting that active Rho has the capacity to promote adherens junction formation (Calautti et al., 2002; Sahai and Marshall, 2002) . Alternatively, inhibition of Rho kinase by its antagonist, Y26732, promotes intercellular adhesion and inhibits EMT suggesting that activation of myosin light chain kinase downstream of Rho plays a role in disrupting the adherens junction (Kaartinen et al., 2002; Lu et al., 2001) . Further studies of the signaling pathways altered by VCAM-1 in epicardium should allow us to elucidate some of the cellular mechanisms that control Rho signaling, cortical actin filament formation and β-catenin localization at the intercellular junction, all events that perform important roles in regulating EMT.
What is the utility of rat EMCs in the study of epicardial EMT and differentiation?
With the experiments presented in this manuscript, we provide evidence that the rat EMC line is a useful tool in the study of epicardial cells. As reported by Wada et al. (2003) , rat EMCs form polarized epithelia that can be passaged to generate large numbers of cells. This makes it possible to carry out biochemical assays that require large amounts of protein, for example cell fractionation studies. The ability to passage these cells also makes it possible to accurately repeat biochemical studies to facilitate quantitative analysis. Additionally, given the relative ease of culture of these cells, it will be possible to generate genetically altered sub lines to study the role of specific molecules or pathways. These types of experiments will complement studies done in other experimental models such as chick embryos and transgenic mice and play an important role in unraveling the signaling pathways that both positively and negatively regulate epicardial EMT. At the same time, the utility of these cells is not unlimited. Confluent EMCs did not undergo a morphologic EMT at the concentrations of TGFβ that we used (1 ng/ml and 10 ng/ml). Wada et al. (2003) reported that the EMCs transitioned in response to epidermal growth factor and fibroblast growth factor, but this required the addition of relatively high concentrations of these factors (40 ng/ml) or calcium free culture conditions, which disrupt cadherin based intercellular adhesion. An interesting consideration is that embryonic epicardial cells lose their ability to undergo EMT during later stages of embryogenesis and there is no explanation for this. Rat EMCs were isolated from adult rat hearts and given that rat EMCs are particularly resilient in their ability to remain epithelial, they may represent epicardium in an "adult" state that cannot undergo EMT. Studying the differences between adult and embryonic epicardium may, in the end, be useful in understanding an important developmental switch that prevents epicardial EMT and vasculogenic differentiation of adult epicardium.
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